On this page
- TL;DR
- Pulmonary fibrosis VA rating criteria (DC 6825)
- Pulmonary function tests for a VA rating: the § 4.96 rules
- Is pulmonary fibrosis presumptive? The PACT Act rule (38 U.S.C. § 1120)
- How to prove pulmonary fibrosis is service connected without the presumption
- Pulmonary fibrosis and COPD or other lung ratings
- Pulmonary fibrosis claim checklist: records and the C&P exam
- Why VA denies pulmonary fibrosis claims
- Questions veterans ask about pulmonary fibrosis
- Bottom Line
- Related Conditions and Tools
- Sources and limits
Pulmonary fibrosis involves two separate VA questions. The percentage comes from the General Rating Formula for Interstitial Lung Disease in 38 CFR § 4.97. Service connection may be presumed under 38 U.S.C. § 1120 when pulmonary fibrosis becomes manifest in a covered veteran as defined by § 1119(c).
The presumption can establish the connection to service. It does not set the percentage. VA still needs current pulmonary-function or severe cardiopulmonary evidence to assign 10, 30, 60, or 100 percent.
This page covers the pulmonary fibrosis rating criteria, the breathing-test rules VA applies, the PACT Act presumption and who qualifies, direct service connection, how pulmonary fibrosis combines with COPD and other lung ratings, and why VA denies pulmonary fibrosis claims.
TL;DR
- DC 6825 covers diffuse interstitial fibrosis, and DCs 6825 through 6833 use the General Rating Formula for Interstitial Lung Disease.
- The formula provides 10, 30, 60, and 100 percent levels.
- The main measurements are FVC and DLCO (SB), with exercise capacity and certain severe findings also controlling at the higher levels.
- Section 4.96 explains when PFTs are required, which bronchodilator results to use, and what happens when test values point to different ratings.
- Pulmonary fibrosis is listed directly in 38 U.S.C. § 1120(b)(10). It is not a 38 CFR § 3.320 condition.
- The statutory presumption applies only when the veteran meets the covered-service definition in 38 U.S.C. § 1119(c).
- Coexisting listed respiratory ratings generally do not stack. VA assigns one predominant respiratory evaluation under § 4.96.
- Across 707 decided Board rulings on pulmonary fibrosis from 2021 to 2026, 34.8% were granted, 25.0% denied and 40.2% remanded. That grant rate is 10.1 points above the Board-wide 24.7 percent.
Pulmonary fibrosis VA rating criteria (DC 6825)
The interstitial-lung-disease formula applies to DCs 6825 through 6833. The clinician's diagnosis controls the exact code. DC 6825 is diffuse interstitial fibrosis, while other interstitial diagnoses have their own codes within the same formula.
10 percent
FVC of 75 to 80 percent predicted, or DLCO (SB) of 66 to 80 percent predicted.
30 percent
FVC of 65 to 74 percent predicted, or DLCO (SB) of 56 to 65 percent predicted.
60 percent
FVC of 50 to 64 percent predicted, DLCO (SB) of 40 to 55 percent predicted, or maximum exercise capacity of 15 to 20 ml/kg/min oxygen consumption with cardiorespiratory limitation.
100 percent
Any one of the following can support the top level.
- FVC below 50 percent predicted;
- DLCO (SB) below 40 percent predicted;
- maximum exercise capacity below 15 ml/kg/min oxygen consumption with cardiorespiratory limitation;
- cor pulmonale;
- pulmonary hypertension; or
- required outpatient oxygen therapy.
Use the predicted percentage, not the raw test value. Keep the complete report because the interpretation, bronchodilator status, test validity, and examiner explanation can control which number VA uses.
Pulmonary function tests for a VA rating: the § 4.96 rules
Section 4.96 applies special rules to DCs 6825 through 6833.
- PFTs are generally required unless a listed severe alternative is already documented, such as qualifying exercise capacity, pulmonary hypertension, cor pulmonale, right-ventricular hypertrophy, acute respiratory failure, or outpatient oxygen therapy.
- If DLCO (SB) is absent, the examiner must explain why that test would not be useful or valid before VA relies on alternatives.
- When the PFTs do not match the clinical findings, VA still rates on the PFTs unless the examiner explains why they are not a valid measure of the impairment.
- Post-bronchodilator studies are normally required for a disability evaluation unless pre-bronchodilator results are normal or the examiner explains why post-testing should not be performed.
- VA normally uses post-bronchodilator values. If those values are poorer than the pre-bronchodilator values, it uses the pre-bronchodilator results.
- When different PFT values would produce different percentages, VA uses the result the examiner says most accurately reflects the disability.
These rules prevent a claimant or rater from simply selecting the lowest number on the page without reading the medical interpretation.
Is pulmonary fibrosis presumptive? The PACT Act rule (38 U.S.C. § 1120)
Section 1120(b)(10) lists pulmonary fibrosis as a specified disease. Under § 1120(a), the disease is presumed incurred in or aggravated by service when it becomes manifest in a covered veteran, subject to the statute's rebuttal rules. Section 1120(c) adopts the covered-veteran definition from 38 U.S.C. § 1119(c), which identifies qualifying locations, airspace, and periods. Section 1120 also lists interstitial lung disease as a separate item, and the rating schedule groups pulmonary fibrosis with the other interstitial lung diseases under DCs 6825 through 6833.
You are a covered veteran if you served while assigned to a duty station in one of these places, including the airspace above it.
- Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, or the United Arab Emirates, on or after August 2, 1990.
- Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, or Uzbekistan, or another country VA determines is relevant, on or after September 11, 2001.
Section 1120 sets no time limit for when the disease appears after service. VA can rebut the presumption with affirmative evidence against it, such as a recognized cause that occurred after separation (38 U.S.C. § 1113).
This is a statutory PACT Act route. It should not be cited as 38 CFR § 3.320, which covers a different set of respiratory diseases and cancers. It also should not be reduced to “burn-pit exposure equals a grant.” The record still needs a current pulmonary-fibrosis diagnosis and proof that the veteran meets the statutory service definition.
For the presumptive route, preserve the following.
- the diagnosis and medical subtype;
- service records establishing a qualifying location and period; and
- current severity evidence for the percentage.
The presumption addresses nexus. It does not choose DC 6825 automatically or replace current PFT evidence.
How to prove pulmonary fibrosis is service connected without the presumption
A veteran who does not meet § 1119(c) can still pursue direct service connection under 38 CFR § 3.303. That route needs a current diagnosis, an in-service disease, event, or exposure, and competent medical evidence linking the two.
Document the actual exposure history, including duty location, duration, protective equipment, and available service records. Do not assume that asbestos, silica, chemicals, or particulate matter caused the individual veteran's disease without a medical opinion addressing timing, dose, diagnosis, and competing causes.
If you have evidence of a toxic exposure risk activity in service, such as an entry in an exposure tracking record, 38 U.S.C. § 1168 requires VA to provide an exam and get a medical opinion on whether your pulmonary fibrosis is at least as likely as not linked to that exposure, unless VA finds no indication of an association. The examiner must consider your total exposure across all deployments and the combined effect of all your toxic exposure risk activities.
Pulmonary fibrosis and COPD or other lung ratings
Section 4.96(a) generally prohibits combining ratings under DCs 6600 through 6817 and 6822 through 6847. VA assigns one evaluation under the code reflecting the predominant disability and may elevate to the next level when overall severity warrants it.
This matters when the record also lists COPD, chronic bronchitis, constrictive bronchiolitis, or another interstitial disease. The diagnoses still matter, but their overlapping respiratory impairment is not normally paid as stacked schedular percentages.
Pulmonary fibrosis claim checklist: records and the C&P exam
Keep the service-connection and rating evidence in separate rows so one does not get mistaken for the other.
| Question | Record to identify | Detail to preserve |
|---|---|---|
| Is pulmonary fibrosis diagnosed? | Pulmonology note, imaging interpretation, or other diagnostic record | Exact diagnosis and subtype, author, and date |
| Does the PACT Act service category fit? | Deployment or other service records | Actual location and dates; compare them with VA's current covered-service list |
| What do the breathing tests show? | Complete PFT report | FVC and DLCO percent predicted, test date, validity, and the clinician's interpretation |
| Is another severe finding relevant? | Oxygen prescription or cardiopulmonary records, if applicable | What is actually documented and required, without assuming the highest category |
| How does it affect daily activity? | Your account and relevant treatment notes | Real examples of limitations, variation, and treatment response |
Fictional example: a report contains an FVC result and a different DLCO result that would point to different levels in the table. Keep the full report and the examiner's explanation of which result best reflects the disability. Do not copy the lower number alone into a statement and call it the assigned rating.
For the service question, Claim Raven's presumptive-conditions tool can help organize a possible match. Verify the diagnosis, dates, and location against VA's current PACT Act guidance. The presumption does not replace the medical evidence used to evaluate severity.
Why VA denies pulmonary fibrosis claims
Across 707 decided Board rulings on pulmonary fibrosis from 2021 to 2026, 34.8% were granted, 25.0% denied and 40.2% remanded. That grant rate is 10.1 points above the Board-wide 24.7 percent, measured over 1,239,429 decided rulings.
Too few pulmonary fibrosis service connection claims were denied for a reliable breakdown of denial reasons, so the list below is a set of issues to check in your decision, not measured frequencies from Board appeals.
- Treating the PACT Act presumption as the rating percentage.
- Citing § 3.320 instead of the § 1120 statutory pulmonary-fibrosis presumption.
- Claiming the presumption without service records that place you at a duty station in a covered location during the covered period.
- For a direct claim, relying on exposure alone without a medical opinion that addresses timing, dose, diagnosis, and competing causes.
- Calling every pulmonary-fibrosis subtype DC 6825 without checking the diagnosis.
- Using a raw PFT number rather than percent predicted.
- Choosing the worse PFT value without the examiner analysis required by § 4.96.
- Omitting DLCO without an explanation.
- Adding overlapping respiratory percentages despite § 4.96(a).
When the Board sends a pulmonary fibrosis claim back instead of deciding it, the most common reason is an inadequate VA exam or opinion, followed by records VA still has to get. In the Board's service connection rulings, direct claims and claims argued under a presumption were granted at similar rates, and secondary claims less often. Rating appeals were granted a little more often than service connection claims. The Board section below shows the remand reasons and both comparisons.
Questions veterans ask about pulmonary fibrosis
Is pulmonary fibrosis a VA presumptive condition?
Yes, for covered veterans. 38 U.S.C. § 1120(b)(10) lists pulmonary fibrosis, and VA presumes it was incurred in service when it appears in a veteran who served at a duty station in a covered location, such as Iraq, Kuwait, Somalia, Afghanistan, or Djibouti, during the covered period. It is a statutory presumption, not a 38 CFR § 3.320 condition.
What is the VA rating for pulmonary fibrosis?
VA rates pulmonary fibrosis at 10, 30, 60, or 100 percent under the General Rating Formula for Interstitial Lung Disease, mainly by FVC and DLCO (SB) as a percent of predicted. For example, an FVC of 50 to 64 percent predicted or a DLCO (SB) of 40 to 55 percent predicted supports 60 percent. Exercise capacity, cor pulmonale, pulmonary hypertension, and outpatient oxygen also count at the higher levels.
How does VA rate interstitial lung disease?
DCs 6825 through 6833 all use the same General Rating Formula for Interstitial Lung Disease. That group includes diffuse interstitial fibrosis, hypersensitivity pneumonitis, pneumoconiosis such as silicosis, and asbestosis. The diagnosis picks the code, and the breathing tests pick the percentage.
Does oxygen therapy mean a 100 percent rating for pulmonary fibrosis?
If outpatient oxygen therapy is required, yes. The interstitial lung disease formula lists required outpatient oxygen therapy as one of the findings that supports 100 percent, along with cor pulmonale, pulmonary hypertension, FVC below 50 percent predicted, and DLCO (SB) below 40 percent predicted.
Can I get separate VA ratings for pulmonary fibrosis and COPD?
No, not as two stacked respiratory ratings. 38 CFR § 4.96(a) bars combining ratings under DCs 6600 through 6817 and 6822 through 6847, and both conditions are rated within that range. VA assigns one rating under the code for the predominant disability and can raise it one level when the overall disability warrants it.
Bottom Line
The pulmonary-fibrosis percentage comes from the interstitial-lung-disease formula and the application rules in § 4.96. The PACT Act presumption is a separate statutory route under §§ 1119 and 1120. A complete record proves the exact diagnosis, qualifying service when claimed, and the current FVC, DLCO, exercise-capacity, oxygen, or cardiopulmonary findings that set the evaluation.
Related Conditions and Tools
Compare chronic bronchitis, COPD, constrictive bronchiolitis, and sarcoidosis. Review DC 6825 and organize exposure and functional evidence with the Statement Builder.
Sources and limits
Legal sources: 38 CFR § 4.96, § 4.97, 38 U.S.C. § 1119, § 1120, 38 U.S.C. §§ 1113 and 1168, 38 CFR § 3.320, and 38 CFR § 3.303, checked October 6, 2026.
Practical checklist and VA PACT Act guidance reviewed September 8, 2026. The example is fictional.
Board figures come from Claim Raven's read of 510,968 Board decisions from 2021 to 2026, which contain 1,376,193 rulings; dismissed, withdrawn and moot rulings are excluded from the shares. These are appealed claims, not your personal odds.
